We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WWD:NASDAQWoodward, Inc. Analysis

Data as of 2026-09-16 - not real-time

$319.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Woodward, Inc. is neutral at $319.50, with no clear ordering between short and long averages. Over a rolling month the price has lost 12.1%. With RSI at 31.4 the momentum picture is approaching oversold, alongside a bearish MACD signal. Recent trading has carved out support near $314.81 and resistance around $371.66.
Multiples put this in fair territory: 35.5 times earnings against the sector's 27.4. Sell-side targets cluster 37.9% above the current quote. Revenue is growing at 21.2% on a 13.2% profit margin. The 0.39% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 30.2%, a beta of 1.26 and a maximum drawdown of 26.8%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting and some less so...Woodward stock draws attention as third-quarter fiscal 2026 net sales rose 26% in Industrial to USDFORT COLLINS, Colo., July 29, 2026 GLOBE NEWSWIRE -- Woodward, Inc. NASDAQ:WWD today reported financial results for its...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 361.72
  • MACD momentum is negative
  • 30-day price change of -12.1%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 35.5 versus sector average of 27.4
  • Trading below the 200-day average of 361.72
  • Analyst targets imply +37.9% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 35.5 versus sector average of 27.4
  • Analyst targets imply +37.9% versus the current price
  • Revenue growth of +21.2%

Key Metrics & Analysis

Financial Health

Revenue Growth21.20%
Profit Margin13.17%
P/E Ratio35.5
ROE22.34%
ROA8.62%
Debt/Equity55.94
P/B Ratio7.5
Op. Cash Flow$585.3M
Free Cash Flow$187.2M
Industry P/E27.4

Technical Analysis

TrendNeutral
RSI31.4
Support$314.81
Resistance$371.66
MA 20$340.52
MA 50$367.77
MA 200$361.72
MACDBearish
VolumeStable
Fear & Greed Index91.25

Valuation

Fair Value$76.78
Target Price$440.67
Upside/Downside37.92%
GradeFair
TypeGrowth
Dividend Yield0.39%

Risk Assessment

Beta1.26
Volatility30.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.